medRxiv PreprintsInternational15 November 2026
Acute Dose-Response Effects of Guarana and Caffeine on Cognitive Performance in Healthy Adults
This is an official announcement record
Firsthand records what medRxiv Preprints announced and links to the original. The wording below is theirs, not ours.
Guarana (Paullinia cupana) is a fruit native to the Brazilian Amazon. It exerts potential cognitive-enhancing effects, primarily attributed to its caffeine content and additional bioactive compounds. However, the dose-response relationship of guarana and its comparative effects on cognitive performance to caffeine remain unclear. This double-blind, placebo-controlled, randomised crossover study aimed to investigate the acute effects of guarana at three different doses (containing 1, 2, and 4 mg*kg*bodyweight-1 caffeine) compared to matched-dose caffeine (4 mg*kg*bw-1) and placebo on cognitive
Read the official announcement
Opens www.medrxiv.org
More from medRxiv Preprints
- Unmet needs of Polish patients with cystic fibrosis seen through the lens of crowdfunding20 November 2026
- Motherly Plus: Study Protocol of a Randomized Controlled Trial Evaluating a Smartphone-Assisted Single-Session Psychotherapy Intervention for Postpartum Depression20 November 2026
- Targeting memory consolidation in major depression via pharmacological slow-wave sleep promotion20 November 2026
- Epidemiology of Cardiac Structure and Function Among African Caribbeans in Tobago: A Population-based Cohort Study20 November 2026
- Depressive Symptom Trajectories and Incident Cognitive Impairment by Outcome Ascertainment20 November 2026
This content is for informational purposes only and is not medical advice. It is not intended to diagnose, treat, cure, or prevent any disease. Consult a healthcare professional before starting any supplement, treatment, or program: especially if you are pregnant, nursing, taking medication, or managing a health condition.